Identification of amino acids in the nicotinic acetylcholine receptor agonist binding site and ion channel photolabeled by 4-[(3-trifluoromethyl)-3H-diazirin-3-yl]benzoylcholine, a novel photoaffinity antagonist

被引:18
|
作者
Chiara, DC [1 ]
Trinidad, JC [1 ]
Wang, D [1 ]
Ziebell, MR [1 ]
Sullivan, D [1 ]
Cohen, JB [1 ]
机构
[1] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA
关键词
D O I
10.1021/bi0269815
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
[H-3]4-[(3-trifluoromethyl)-3H-diazirin-3-yl]benzoylcholine (TDBzcholine) was synthesized and used as a photoaffinity probe to map the orientation of an aromatic choline ester within the agonist binding sites of the Torpedo nicotinic acetylcholine receptor (nAChR). TDBzcholine acts as a nAChR competitive antagonist that binds at equilibrium with equal affinity to both agonist sites (K-D similar to 10 muM). Upon UV irradiation (350 nm), nAChR-rich membranes equilibrated with [H-3]TDBzcholine incorporate H-3 into the alpha, gamma, and delta subunits in an agonist-inhibitable manner. The specific residues labeled by [H-3]TDBzcholine were determined by N-terminal sequence analysis of subunit fragments produced by enzymatic cleavage and purified by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and/or reversed-phase high-performance liquid chromatography. For the alpha subunit, [H-3]TDBzcholine photoincorporated into alphaCys192, alphaCys-193, and alphaPro-194. For the gamma and delta subunits, [H-3]TDBzcholine incorporated into homologous leucine residues, gammaLeu-109 and deltaLeu-111. The photolabeling of these amino acids suggests that when the antagonist TDBzcholine occupies the agonist binding sites, the Cys- 192-193 disulfide and Pro-194 from the alpha subunit Segment C are oriented toward the agonist site and are in proximity to gammaLeu- 109/deltaLeu-111 in Segment E, a conclusion consistent with the structure of the binding site in the molluscan acetylcholine binding protein, a soluble protein that is homologous to the nAChR extracellular domain.
引用
收藏
页码:271 / 283
页数:13
相关论文
共 50 条
  • [41] WS-50030 [7-{4-[3-(1H-inden-3-yl)propyl]piperazin-1-yl}-1,3-benzoxazol-2(3H)-one]: A Novel Dopamine D2 Receptor Partial Agonist/Serotonin Reuptake Inhibitor with Preclinical Antipsychotic-Like and Antidepressant-Like Activity
    Brennan, Julie A.
    Graf, Radka
    Grauer, Steven M.
    Navarra, Rachel L.
    Pulicicchio, Claudine M.
    Hughes, Zoe A.
    Lin, Qian
    Wantuch, Caitlin
    Rosenzweig-Lipson, Sharon
    Pruthi, Farhana
    Lai, Margaret
    Smith, Deborah
    Goutier, Wouter
    van de Neut, Martina
    Robichaud, Albert J.
    Rotella, David
    Feenstra, Rolf W.
    Kruse, Chris
    Broqua, Pierre
    Beyer, Chad E.
    McCreary, Andrew C.
    Pausch, Mark H.
    Marquis, Karen L.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 332 (01): : 190 - 201
  • [42] Pharmacological Characterization of (3S)-3-(Hydroxymethyl)-4-(5-Methylpyridin-2-yl)-N-[6-(2,2,2-Trifluoroethoxy)pyridin-3-yl]-3,4-Dihydro-2H-Benzo[b][1,4]Oxazine-8-Carboxamide (JTS-653), a Novel Transient Receptor Potential Vanilloid 1 Antagonist
    Kitagawa, Yoshihiro
    Miyai, Atsuko
    Usui, Kenji
    Hamada, Yuji
    Deai, Katsuya
    Wada, Masashi
    Koga, Yoshihisa
    Sakata, Masahiro
    Hayashi, Mikio
    Tominaga, Makoto
    Matsushita, Mutsuyoshi
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2012, 342 (02): : 520 - 528
  • [43] The translational pharmacology of a novel, potent, and selective nonsteroidal progesterone receptor antagonist, 2-[4-(4-cyano-phenoxy)-3,5-dicyclopropyl-1H-pyrazol-1-yl]-N-methylacetamide (PF-02367982)
    de Giorgio-Miller, Alexander
    Bungay, Peter
    Tutt, Michelle
    Owen, Julie
    Goodwin, David
    Pullen, Nick
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 327 (01): : 78 - 87
  • [44] [3H]A-585539 [(1S,4S)-2,2-Dimethyl-5-(6-phenylpyridazin-3-yl)-5-aza-2-azoniabicyclo[2.2.1]heptane], a novel high-affinity α7 neuronal nicotinic receptor agonist:: Radioligand binding characterization to rat and human brain
    Anderson, David J.
    Bunnelle, William
    Surber, Bruce
    Du, Jia
    Surowy, Carol
    Tribollet, Eliane
    Marguerat, Anouk
    Bertrand, Daniel
    Gopalakrishnan, Murali
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 324 (01): : 179 - 187
  • [46] The glycine binding site of the N-methyl-D-aspartate receptor subunit NR1: Identification of novel determinants of co-agonist potentiation in the extracellular M3-M4 loop region
    Hirai, H
    Kirsch, J
    Laube, B
    Betz, H
    Kuhse, J
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (12) : 6031 - 6036
  • [47] Structural elucidation of impurities in 5-n-butyl-4-{4-[2-(1H-tetrazole-5-yl)-1H-pyrrol-1-yl]phenylmethyl}-2,4-dihydro-2-(2,6-dichlorophenyl)-3H-1,2,4-triazol-3-one (Ib), a novel nonpeptide angiotensin AT1 receptor antagonist
    Gao, Ting
    Liu, Yaxuan
    Ji, Yibing
    Wu, Xiaoming
    Xu, Jinyi
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2012, 66 : 381 - 386
  • [48] In Vitro Pharmacological Characterization of a Novel Allosteric Modulator of α7 Neuronal Acetylcholine Receptor, 4-(5-(4-Chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744), Exhibiting Unique Pharmacological Profile
    Malysz, John
    Gronlien, Jens Halvard
    Anderson, David J.
    Hakerud, Monika
    Thorin-Hagene, Kirsten
    Ween, Hilde
    Wetterstrand, Caroline
    Briggs, Clark A.
    Faghih, Ramin
    Bunnelle, William H.
    Gopalakrishnan, Murali
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 330 (01): : 257 - 267
  • [49] Novel and potent transforming growth factor beta type I receptor kinase domain inhibitor:: 7-amino 4-(2-pyridin-2-yl-5,6-dihydro-4H-pyrrolol[1,2-b]pyrazol-3-yl)-quinolines
    Li, HY
    Wang, Y
    Yan, L
    Campbell, RM
    Anderson, BD
    Wagner, JR
    Yingling, JM
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (13) : 3585 - 3588
  • [50] Identification of (R)-(2-Chloro-3-(trifluoromethyl)phenyl)(1-(5-fluoropyridin-2-yl)-4-methyl-6,7-dihydro-1H-imidazo[4,5-c]pyridin-5(4H)-yl)methanone (JNJ 54166060), a Small Molecule Antagonist of the P2X7 receptor
    Swanson, Devin M.
    Savall, Brad M.
    Coe, Kevin J.
    Schoetens, Freddy
    Koudriakova, Tatiana
    Skaptason, Judith
    Wall, Jessica
    Rech, Jason
    Deng, Xiahou
    De Angelis, Meri
    Everson, Anita
    Lord, Brian
    Wang, Qi
    Ao, Hong
    Scott, Brian
    Sepassi, Kia
    Lovenberg, Timothy W.
    Carruthers, Nicholas I.
    Bhattacharya, Anindya
    Letavic, Michael A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (18) : 8535 - 8548